Evaluation of genotoxic effects of Apitol® (cymiazole hydrochloride) in vitro by measurement of sister chromatid exchange

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 588, Issue 2, 2005, Pages 152-157

  Stanimirovic, Zoran ^a   Stevanovic, Jevrosima ^a   Jovanovic, Slobodan ^a   Andjelkovic, Marko ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acaricide; Apitol (cymiazole hydrochloride); Genotoxic; Honey; Sister chromatid exchange; Varroa destructor

Indexed keywords

ACARICIDE; CHLORIDE; CYMIAZOLE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LYMPHOCYTE CULTURE; MEASUREMENT; MITOSIS INDEX; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ACARI; APOIDEA; VARROA DESTRUCTOR;

EID: 28944449930     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2005.10.003     Document Type: Article

References (48)

1. U. Eyrich, and W. Ritter Distribution of a systematic functioning medicament in the body of the honey bee Apis mellifera Z. Angewante Entomol. 109 1990 15 20
2. E.W. Herbert Jr., W.A. Bruce, and H. Shimanuki Control of Varroa jacobsoni on honey bees in packages using Apistan Am. Bee J. 128 1988 615 616
3. M.O.M. Omar, and M.N. Shoriete Effect of the systemic acaricide "Apitol" on some physiological characters of honey bee worker Assiut J. Agric. Sci. 23 1992 203 215
4. N. Kezic, D. Lucic, and D.J. Sulimanovic Induction of mixed-function oxidase activity in honey bee as a bioassay for detection of environmental xenobiotics Apidologie 23 1992 217 223
5. I. Floris, C.M. Papoff, and R. Prota Autumnal control of Varroa jacobsoni Oud. with Apitol in a mediterranean environment (N. Sardinia) Apicoltura 10 1995 33 42
6. K. Wallner Varroacides and their residues in bee products Apidologie 30 1999 235 248
7. W. Ritter, B. Jehle, and U. Eyrich Distribution of Apitol, a systemic acaricide, in topical application and in feed Apidologie 18 1987 389
8. F.A. Eischen, A. Dietz, D. Cardoso-Tamez, and C. Vergara Cymiazole, a systemic acaricide that controls Acarapis woodi (Rennie) infesting honey bees. I. Laboratory tests Apidologie 19 1988 367 376
9. F.A. Eischen, A. Dietz, G.O. Ware, and D. Cardoso-Tamez Cymiazole, a systemic acaricide that controls Acarapis woodi (Rennie) infesting honey bees. I. Laboratory tests. II. Apiary tests Apidologie 20 1989 41 51
10. P. Cabras, M. Melis, and L. Spanedda Determination of cymiazole residues in honey by HPLC J. AOAC Int. 76 1993 92 93
11. P. Cabras, M.G. Martini, I. Floris, and L. Spanedda Residue of cymiazole in honey and honey bees J. Apic. Res. 33 1994 83 86
12. M.A. Fernandezmuino, M.T. Sancho, S. Muniategui, J.F. Huidobro, and J. Simallozano Acaricide residues in honey - analytical methods and levels found J Food Prot. 58 1995 449 454
13. E. Corta, A. Bakkali, A. Barranco, L.A. Berrueta, B. Gallo, F. Vicente, and S. Bogdanov Study of the degradation products of brompropylate, chlordimeform, coumaphos, cymiazole, flumethrin and tau-fluvalinate in aqueous media Talanta 52 2000 169 180
14. E. Korta, A. Bakkali, L.A. Berrueta, B. Gallo, F. Vicente, V. Kilchenmann, and S. Bogdanov Study of acaricide stability in honey. Characterization of amitraz degradation products in honey and beeswax J. Agric. Food Chem. 49 2001 5835 5842
15. EMEA-The European Agency for the Evaluation of Medicinal Products, Veterinary Medicines Evaluation Unit, EMEA/MRL/067/96-FINAL Committee for Veterinary Medicinal Products, Summary Report, Cymiazole, March 1996.
16. EMEA-The European Agency for the Evaluation of Medicinal Products, Veterinary Medicines Evaluation Unit, EMEA/CVMP/130/00-FINAL, Committee for Veterinary Medicinal Products, update of the position paper on availability of veterinary medicines agreed on February 2000.
17. ® genotoxic and mutagenic potential? Abstracts from EEMS-99 29th Annual Meeting of the European Environmental Mutagen Society, vol. 85, Suppl. I Copenhagen, Denmark, July 4-9 1999 45
18. B.N. Ames, R. Magaw, and L.S. Gold Ranking possible carcinogenic hazards Science 236 1987 271 280
19. B.N. Ames Mutagenesis and carcinogenesis: endogenous and exogenous factors Environ. Molec. Mut. 14 Suppl. 16 1989 66 77
20. M. Sato, T. Sato, T. Izumo, and T. Amagasa Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer Carcinogenesis 20 1999 1927 1931
21. R.J. Albertini, D. Anderson, G.R. Douglas, L. Hagmar, K. Hemminki, F. Merlo, A.T. Natarajan, H. Norppa, D.E.G. Shuker, R. Tice, M.D. Waters, and A. Aitio IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans Mutat. Res. 463 2000 111 172
22. M. Ingelman-Sundberg Genetic variability in susceptibility and response to toxicants Toxicol. Lett. 120 2001 259 268
23. M.C. Miller, H.W. Mohrenweiser, and D.A. Bell Genetic variability in susceptibility and response to toxicants Toxicol. Lett. 120 2001 269 280
24. M. Poulsen, A.M. Mølck, I. Thorup, V. Breinholt, and O. Meyer The influence of simple sugars and starch given during pre-or post-initiation on aberrant crypt foci in rat colon Cancer Lett. 167 2001 135 143
25. N. Djelic, and D. Djelic Enhanced sister-chromatid exchange rate in human lymphocytes exposed to 17 beta estradiol in vitro Arch. Med. Res. 33 2002 148 151
26. H. Norppa Cytogenetic biomarkers and genetic polymorphisms Toxicol. Lett. 144 Suppl. 1 2003 25
27. N. Aydemir, S. Celikler, and R. Bilaloǧlu In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes Mutat. Res. 582 2005 35 41
28. S. Wolff Sister Chromatid Exchange 1982 Wiley New York
29. H.J. Evans, and M. O'Riordan Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests Mutat. Res. 31 1975 135 148
30. L. Lamberti, P. Bigatti-Ponzetto, and G. Ardito Cell kinetics and sister chromatid exchange frequency in human lymphocytes Mutat. Res. 120 1983 193 199
31. P. Perry, and S. Wolff New Giemsa method for the differential staining of sister chromatids Nature 251 1974 156 158
32. A. Fucic, A. Jazbec, A. Mijic, D. Seso-Simic, and R. Tomek Cytogenetic consequences after occupational exposure to antineoplastic drugs Mutat. Res. 416 1998 59 66
33. S.W. Maluf, and B. Erdtmann Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay Mutat. Res. 471 2000 21 27
34. S. Preston-Martin, M.C. Pike, R.K. Ross, P.A. Jones, and B.E. Henderson Increased cell division as a cause of human cancer Cancer Res. 50 1990 7415 7421
35. G. Ott, T. Katzenberger, A. Lohr, S. Kinderlberger, T. Rüdiger, M. Wilhelm, J. Kalla, A. Rosenwald, J.G. Müller, M.M. Ott, and H.K. Müller-Hermelink Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3 Blood 99 2002 3806 3812
36. W. Lingle, and J. Salisbury Altered centrosome structure is associated with abnormal mitoses in human breast tumors Am. J. Pathol. 155 1999 1941 1951
37. C.J. Sherr, and R.A. DePinho Cellular senescence: mitotic clock or culture shock? Cell 102 2000 407 410
38. W.R. Bruce, M.C. Archer, D.E. Corpet, A. Medline, S. Minkin, D. Stamp, Y. Yin, and X.M. Zhang Diet, aberrant crypt foci and colorectal cancer Mutat. Res. 290 1993 111 118
39. A. Favero, M. Parpinel, and S. Franceschi Diet and risk of breast cancer: major findings from an Italian case-control study Biomed. Pharmacother. 52 1998 109 115
40. Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase Biochem. Pharmacol. 69 2005 1815 1827
41. K.J. Woo, Y.J. Jeong, H. Inoue, J.W. Park, and T.K. Kwon Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity FEBS Lett. 579 2005 705 711
42. K.J. Woo, Y.J. Jeong, J.W. Park, and T.K. Kwon Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells Biochem. Biophys. Res. Co. 325 2004 1215 1222
43. T. Zhang, X. Chen, L. Qu, J. Wu, R. Cui, and Y. Zhao Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in HeLa cells Bioorg. Med. Chem. 12 2004 6097 6105
44. D. Tucker, A. Auletta, M.C. Cimino, K.L. Dearfield, D. Jacobson-Kram, R.R. Tice, and A.V. Carrano Sister chromatid exchange: second report of gene-tox program Mutat. Res. 197 1993 101 180
45. J.D. Tucker, and R.J. Preston Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment Mutat. Res. 365 1996 147 159
46. M. Karbownik, R.J. Reiter, J. Cabrera, and J.J. García Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage Mutat. Res. 474 2001 87 92
47. T. Hu, D.P. Gibson, G.J. Carr, S.M. Torontali, J.P. Tiesman, J.G. Chaney, and M.J. Aardema Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins Mutat. Res. 549 2004 5 27
48. V. Bajic, Z. Stanimirovic, and J. Stevanovic Genotoxicity potential of 8-Cl-cyclic adenosine monophosphate assessed with cytogenetic test in vivo Arch. Med. Res. 35 2004 209 214